Current Drug Delivery
Title:Use of Clays as Nanocarriers of First-Line Tuberculostatic Drugs
Volume: 14 Issue: 7
Author(s): Esperanza Carazo*, Ana Borrego-Sanchez, Carola Aguzzi, Pilar Cerezo and Cesar Viseras
Affiliation:
- Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja, 18071 s/n, Granada,Spain
Export Options
About this article
Cite this article as:
Carazo Esperanza *, Borrego-Sanchez Ana, Aguzzi Carola , Cerezo Pilar and Viseras Cesar , Use of Clays as Nanocarriers of First-Line Tuberculostatic Drugs, Current Drug Delivery 2017; 14 (7) . https://dx.doi.org/10.2174/1567201813666160714160727
DOI https://dx.doi.org/10.2174/1567201813666160714160727 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fabrication and Characterization of Oral Dissolving Films for Tuberculosis Drug Delivery
Nanoscience & Nanotechnology-Asia Natural T Cell Immunity to Intracellular Pathogens and Nonpeptidic Immunoregulatory Drugs
Current Molecular Medicine Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Activation of the Liver X Receptor Inhibits Th17 and Th1 Responses in Behcet`s Disease and Vogt-Koyanagi-Harada Disease
Current Molecular Medicine Isocitrate Lyase: A Potential Target for Anti-Tubercular Drugs
Recent Patents on Inflammation & Allergy Drug Discovery Large Disclosing the Nature of Computational Tools for the Analysis of Next Generation Sequencing Data
Current Topics in Medicinal Chemistry Bedaquiline: A New Hope to Treat Multi-Drug Resistant Tuberculosis
Current Topics in Medicinal Chemistry The Possible Potency of Ocimum basilicum New Constituent on Glucosestimulated Insulin Secretion In Vitro and β-cell Function In Vivo
Letters in Drug Design & Discovery Flexible Bronchoscopy Biopsy Tools and Techniques to Optimize Diagnostic Yield: A Contemporary Review
Current Respiratory Medicine Reviews Antibiotics in the Treatment of Reactive Arthritis
Current Rheumatology Reviews Synthesis of a Tetrasaccharide Present in Motif B of the Mycobacterium tuberculosis Cell Wall
Letters in Organic Chemistry Blood Pressure Measurement: Lessons Learned from Our Ancestors
Current Pharmaceutical Design Editorial (Thematic Issue: The Lab-on-a-protein Concept Protein as Powerful Nanometric Laboratory for Chemical Sciences)
Current Organic Chemistry The Aromatic Stacking Interactions Between Proteins and their Macromolecular Ligands
Current Protein & Peptide Science Antimycotic Drugs and their Mechanisms of Resistance to <i>Candida</i> Species
Current Drug Targets Increase of R-/S-Methadone Enantiomer Concentration Ratio in Serum of Patients Treated with Either Nevirapine or Efavirenz
Drug Metabolism Letters The Use of Proteomics to Study Infectious Diseases
Infectious Disorders - Drug Targets Anticonvulsant and Antitubercular Activities of 6-Phenyl/Biphenyl-4-yl-2- [2-(pyridin-2-ylamino)-ethyl]- and 6-(Biphenyl-4yl)-2-(2N-subtituted amin- 1-yl)-ethyl derivatives of 4,5-dihydropyridazin-3(2H)-one
Letters in Drug Design & Discovery Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued)